An Estimate of the Size of the US Predialysis Population With Renal Insufficiency and Anemia
- 1 March 1993
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 21 (3) , 264-269
- https://doi.org/10.1016/s0272-6386(12)80744-x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Double-Blind, Placebo-Controlled Study of the Therapeutic Use of Recombinant Human Erythropoietin for Anemia Associated With Chronic Renal Failure in Predialysis PatientsAmerican Journal of Kidney Diseases, 1991
- The Use of Recombinant Human Erythropoietin in the Correction of Anemia in Predialysis Patients and Its Effect on Renal Function: A Double-Blind, Placebo-Controlled TrialAmerican Journal of Kidney Diseases, 1989
- Analysis of the Quantitative Relationship Between Anemia and Chronic Renal FailureThe Lancet Healthy Longevity, 1989
- Effects of Human Recombinant Erythropoietin on Anaemia, Systemic Haemodynamics and Renal Function in Predialysis Renal Failure PatientsNephrology Dialysis Transplantation, 1989
- Treatment of the Anemia of Predialysis Patients with Recombinant Human Erythropoietin: A Randomized, Placebo-Controlled TrialThe Lancet Healthy Longevity, 1988
- Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiencyKidney International, 1984